(Q39215725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Xiao-ming Meng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Rong Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Hui Y Lan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

X Zhong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

A C K Chung

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Y Dong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

W Yang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

F F Hou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

5 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

663-674

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292313%20AND%20SRC:MED&resulttype=core&format=json

Diabetic nephropathy: mechanisms of renal disease progression

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Diabetic nephropathy: important pathophysiologic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Diabetes complications: the microRNA perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Diverse roles of TGF-β/Smads in renal fibrosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Smad3-mediated upregulation of miR-21 promotes renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

miR-192 mediates TGF-beta/Smad3-driven renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Identification of a microRNA signature in renal fibrosis: role of miR-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Inflammatory mechanisms of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

The role of inflammatory cytokines in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Identification of a microRNA signature of renal ischemia reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

MicroRNA-21: a novel therapeutic target in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2804-X

Prevention of decline in renal function in the diabetic db/db mouse

21 January 2018

1 reference

12 December 2020

Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse.

1 reference

12 December 2020

MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways

1 reference

12 December 2020

Mouse models of diabetic nephropathy

1 reference

12 December 2020

In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes

1 reference

12 December 2020